The funding comes through the New Jersey Alliance for Clinical and Translational Science, an organization led by Rutgers that collaborates with partners including Princeton University, the New Jersey Institute of Technology and RWJBarnabas Health, according to an Oct. 30 news release. The alliance — which formed in 2019 with an initial $29 million from the National Institutes of Health — comprises scientists, healthcare providers, patient advocacy organizations and community members.
The new funding will support seven years of research focused on:
- Developing opioid overdose prevention practices
- Preventing maternal mortality
- Studying childhood asthma and environmental toxins
- Launching and promoting clinical trials, including complex non-oncology trials such as gene therapy
- Building community-engagement research networks
- Creating a more diverse workforce
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
